Here are some encouraging medical research developments achieved over the weekend related to the fight against the novel coronavirus.MedicationThree existing drugs that showed promise in inhibiting the novel coronavirus in vitro have entered human trials in China, and early results have showed that
As researchers in the pharmaceutical industry seek to contain the novel coronavirus epidemic, Tao Xinliang, honorary dean of the Intellectual Property Institute of Shanghai University, shares his insights into related patent issues.Can a new patent be filed for an old drug due to novel use?When it i
The Wuhan Institute of Virology, part of the China Academy of Sciences, has applied to patent the use of Gilead Sciences' remdesivir to treat the current coronavirus outbreak.The company has partnered with Chinese health authorities to run a Phase III clinical trial to assess remdesivir for trea
Seminar on Building High Value Patent Portfolio Strategies by Making Good Use of Science and Technology was Successfully Held in Shenzhen
U.S. Patent Ranking: Huawei Beijing Oriental Ranked in The Top 20, While Apple Intel Ranked Down
